European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
Date: September 25, 2023
The EMA has opened a public consultation on a reflection paper presenting views on artificial intelligence and machine learning at any step of the lifecycle of human and veterinary medicines, from drug discovery to the post-authorisation setting.
All interested stakeholders are invited to comment on the draft reflection paper and to identify opportunities and risks of AI in the field of medicines – deadline: 31 December 2023
The topic will be further discussed during a joint HMA/EMA workshop scheduled for 20-21 November 2023.
The feedback from stakeholders will be analysed and considered for the finalisation of the reflection paper and future development of guidance as relevant.
Find out more here.
Explore More News

Regulatory Considerations DMEG Update – September 2024
The Regulatory Considerations DMEG are waiting for the release of ICH GCP E6 (R3) Annex 1 . . .
Read More

Digital Data Flow (DDF) integration through the lens of electronic Patient-Reported Outcomes (ePRO)
This article has been submitted by Leeni Joshua of ICON plc
Introduction:
Digital Data . . .
Read More

Guidance for Industry: Conducting Clinical Trials With Decentralized Elements
The Conducting Clinical Trials With Decentralized Elements final guidance has now been . . .
Read More

Welcome FGK Clinical Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome FGK Clinical . . .
Read More

Welcome LINK Medical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome LINK Medical as . . .
Read More

Welcome Zilla Clinicals as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Zilla Clinicals . . .
Read More

Challenge ChatGPT: CDMs vs AI
Following a recent Hot Topic discussion that explained how machine learning models are . . .
Read More

Welcome Boehringer Ingelheim as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Boehringer . . .
Read More

Welcome Datacapt as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Datacapt as a . . .
Read More

Welcome Climedo as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .
Read More

Clinical Trials for Medicines – New Notification Scheme
The MHRA have recently launched a new notification scheme, the first step in their . . .
Read More

EMA Management Board: Highlights of October 2023 meeting
The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .
Read More